SAB Biotherapeutics (SABS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

SABS is expected to report earnings to fall 16.67% to -83 cents per share on March 28

SAB Biotherapeutics SABS Stock Earnings Reports

Q4'23

Est.

$-0.83

Q3'23

Missed

by $0.88

Q2'23

Missed

by $1.26

Q1'23

Missed

by $1.39

Q4'22

Missed

by $1.71

The last earnings report on November 14 showed earnings per share of -100 cents, missing the estimate of -11 cents. With 84.88K shares outstanding, the current market capitalization sits at 28.61M.

View a ticker or compare two or three

Compare

SABS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SABS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2100 East 54th Street North

Phone

+1 605 679-6980

Employees

Web

https://www.sabbiotherapeutics.com